David C. Fisher is an Instructor of Medicine at Harvard Medical School, and at Dana-Farber Cancer Institute in the Department of Medical Oncology. He attends on the lymphoma and bone marrow transplant services at the Brigham & Women's Hospital and is the oncologist providing specialty care in the Cutaneous Lymphoma Clinic in conjunction with the department of dermatology. His research interests are in the use of novel drug combinations in an effort to improve therapy for different subtypes of lymphoma. He has a particular interest in the evolving field of new immunotherapies and radioimmunotherapies. He is also conducting clinical trials evaluating the use of high-dose chemotherapy with autologous or allogeneic bone marrow transplant.
Dr. Fisher received his MD from the University of Massachusetts Medical School and served his residency training at the Duke University Medical Center where he also served clinical fellowships in infectious diseases, hematology-oncology and bone marrow transplantation.
